We are live on ! Find out more
WA

Wilshire Advisors Portfolio holdings

AUM $9.96M
1-Year Est. Return 76.57%
This Fund
S&P 500
This Quarter Est. Return
+66.93%
1 Year Est. Return
+76.57%
3 Year Est. Return
+100.3%
5 Year Est. Return
+82.67%
10 Year Est. Return
+137%
AUM
$38.6M
AUM Growth
+$27.5M
Cap. Flow
+$21.3M
Cap. Flow %
55.09%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
3
Closed

Top Buys

Rank Stock Value
1
LDI icon
loanDepot
LDI
+$12.7M
2
FATE icon
Fate Therapeutics
FATE
+$9.15M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$1.19M

Sector Composition

Rank Sector Weight
1 Financials 43.95%
2 Healthcare 27.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDI icon
1
loanDepot
LDI
$548M
$17M 43.95%
5,524,652
+5,496,925
+19,825% +$12.7M
FATE icon
2
Fate Therapeutics
FATE
$281M
$10.7M 27.71%
+8,486,822
New +$9.15M
IEFA icon
3
iShares Core MSCI EAFE ETF
IEFA
$186B
$4.28M 11.09%
48,993
-2,738
-5% -$233K
AGG icon
4
iShares Core US Aggregate Bond ETF
AGG
$138B
$2.41M 6.25%
24,041
+11,961
+99% +$1.19M
IJR icon
5
iShares Core S&P Small-Cap ETF
IJR
$109B
$1.83M 4.75%
15,430
-12,690
-45% -$1.46M
IGSB icon
6
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$1.8M 4.67%
33,981
IEMG icon
7
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$611K 1.58%
9,265
-1,368
-13% -$85.3K

Similar funds

Wilshire Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Wilshire Advisors held 7 positions worth $38.6M, up 249% from $11.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Wilshire Advisors deployed $21.3M of net new capital in Q3 2025, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Fate Therapeutics: 8,486,822 shares worth $10.7M.

By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 0.32% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $1.46M trimmed.

  • Wilshire Advisors's largest Q3 2025 buy was Fate Therapeutics: 8,486,822 shares worth $10.7M.
  • Wilshire Advisors added most to loanDepot in Q3 2025, an estimated $12.7M increase.
  • Wilshire Advisors's biggest Q3 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $1.46M.
  • Wilshire Advisors's ten largest holdings make up 100% of its $38.6M portfolio in Q3 2025.
  • Wilshire Advisors opened 1 new position and closed 0 in Q3 2025.
  • Wilshire Advisors's portfolio value rose 249% quarter-over-quarter to $38.6M.

Based on Wilshire Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.